Elevated expression of KDM5A/B has been detected in a small subpopulation of slowly proliferating, tumor-initiating cells that show intrinsic resistance to a wide variety of cancer therapeutics, including cytotoxic and targeted agents [38]. Here, KDM5A is linked to cancer.